Analysts think NAGE stock price could increase by 37%
Apr 07, 2025, 11:25 AM
45.30%
What does NAGE do
Chromadex is a Los Angeles-based bioscience company focused on developing proprietary ingredient technologies, including NAD+ research. It operates through Consumer Products, Ingredients, and Analytical Reference Standards segments, employing 106 staff since its IPO in 2007.
6 analysts think NAGE stock price will increase by 36.51%. The current median analyst target is $8.21 compared to a current stock price of $6.01. The lowest analysts target is $8.08 and the highest analyst target is $12.60.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
